These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6316304)

  • 21. The role of the NKG2D receptor for tumor immunity.
    Coudert JD; Held W
    Semin Cancer Biol; 2006 Oct; 16(5):333-43. PubMed ID: 16914326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intercellular bonds in different forms of stomach cancer growth].
    Lobanov SL
    Vopr Onkol; 1982; 28(11):30-2. PubMed ID: 7147828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protean immune cell synapse: a supramolecular structure with many functions.
    Davis DM; Igakura T; McCann FE; Carlin LM; Andersson K; Vanherberghen B; Sjöström A; Bangham CR; Höglund P
    Semin Immunol; 2003 Dec; 15(6):317-24. PubMed ID: 15001170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Junctional structures and hepatocellular carcinoma: from the lab to the clinic?
    Vinken M; Vanhaecke T; Rogiers V
    Liver Int; 2008 Apr; 28(4):432-4. PubMed ID: 18339070
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Swords into plowshares: IL-23 repurposes tumor immune surveillance.
    Langowski JL; Kastelein RA; Oft M
    Trends Immunol; 2007 May; 28(5):207-12. PubMed ID: 17395538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.
    Mantovani A; Allavena P; Sica A
    Eur J Cancer; 2004 Jul; 40(11):1660-7. PubMed ID: 15251154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumor cells and their microenvironment].
    Vasil'ev IuM
    Vopr Onkol; 1984; 30(2):96-103. PubMed ID: 6322447
    [No Abstract]   [Full Text] [Related]  

  • 29. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 30. The biological significance of the immune response with special reference to parasites and cancer.
    Davies AJ; Hall JG; Targett GA; Murray M
    J Parasitol; 1980 Oct; 66(5):705-21. PubMed ID: 7463241
    [No Abstract]   [Full Text] [Related]  

  • 31. A fresh look at tumor immunosurveillance and immunotherapy.
    Smyth MJ; Godfrey DI; Trapani JA
    Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKG2D ligands in tumor immunity.
    Nausch N; Cerwenka A
    Oncogene; 2008 Oct; 27(45):5944-58. PubMed ID: 18836475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of cancer stem cells.
    Bapat SA
    Semin Cancer Biol; 2007 Jun; 17(3):204-13. PubMed ID: 16787749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The flip side of immune surveillance: immune dependency.
    Prehn RT; Prehn LM
    Immunol Rev; 2008 Apr; 222():341-56. PubMed ID: 18364013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer.
    Bauskin AR; Brown DA; Kuffner T; Johnen H; Luo XW; Hunter M; Breit SN
    Cancer Res; 2006 May; 66(10):4983-6. PubMed ID: 16707416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class I antigens and immune surveillance in transformed cells.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
    Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An experimental study of intraoral carcinogenesis, especially the changes in the plasma membrane and intercellular junctions in cancer formation and in squamous cell carcinoma].
    Moriya T
    Shikwa Gakuho; 1982 Jun; 82(6):761-79. PubMed ID: 6817418
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cellular adaptation and cancerogenesis].
    La Torre F; Silpigni A; Tomasello R; Picone GS; La Torre I; Aragona M
    Minerva Med; 1998 Jun; 89(6):229-39. PubMed ID: 9739355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the criticism of antitumor immunity: arguments for and against].
    Revskoĭ SIu; Dil'man VM
    Vopr Onkol; 1988; 34(4):477-81. PubMed ID: 3287765
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.
    Smyth MJ; Dunn GP; Schreiber RD
    Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.